Atossa Therapeutics, Inc. Common Stock (ATOS)
Atossa Therapeutics, Inc. Common Stock (ATOS) has a 19-report earnings history dating back to May 14, 2021. Its average absolute post-earnings move is ±4.90%, and 31.6% of those reactions were positive. Its largest post-earnings gain was +22.46% (May 14, 2021) and its largest decline was -9.67% (Aug 14, 2023). The next earnings report is predicted for 2026-08-12 (high confidence).
Earnings reactions
How ATOS moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±4.90%
Positive %
31.6%
Negative %
68.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jan 09, 2026 | ☀ PRE | -1.37% | open_in_new |
| Nov 12, 2025 | ☀ PRE | -0.8% | open_in_new |
| Aug 12, 2025 | ☀ PRE | +0.81% | open_in_new |
| May 13, 2025 | ☀ PRE | +6.83% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±4.90%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
8 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 424B5 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260611 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
Frequently asked about ATOS earnings
When does Atossa Therapeutics, Inc. Common Stock report earnings next? expand_more
Atossa Therapeutics, Inc. Common Stock (ATOS)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ATOS stock move after earnings? expand_more
Over 19 reports, ATOS has moved an average of ±4.90% the session after earnings, closing higher 31.6% of the time.
What was ATOS's biggest post-earnings move? expand_more
ATOS's largest post-earnings gain on record was +22.46% on May 14, 2021, and its largest decline was -9.67% on Aug 14, 2023.
Where can I find Atossa Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Atossa Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right